Showing results (131-140 of 156) with videos related to
Sort By:
Pageof 16
Plos One|September 17, 2008
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosisMarco Cassano, Stefano Biressi, Amanda Finan, et al.Plos One|July 25, 2019
Correction: Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from ApoptosisMarco Cassano, Stefano Biressi, Amanda Finan, et al.Human Mutation|December 24, 2015
Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next-Generation SequencingAlan S Ma, John R Grigg, Gladys Ho, et al.Trials|July 13, 2014
Sepsis survivors monitoring and coordination in outpatient health care (SMOOTH): study protocol for a randomized controlled trialKonrad Schmidt, Paul Thiel, Friederike Mueller, et al.Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|January 13, 2025
Clinical practices on acute acquired comitant esotropia: A consensus statement proposed by the Council of Asia-Pacific Strabismus and Pediatric Ophthalmology SocietyWen Wen, Sonal K Farzavandi, Miho Sato, et al.The Annals of Thoracic Surgery|March 30, 2023
Pectus Excavatum: Consensus and Controversies in Clinical PracticeNicky Janssen, Jean H T Daemen, Elise J van Polen, et al.Phytopathology|August 22, 2013
Phytophthora database 2.0: update and future directionBongsoo Park, Frank Martin, David M Geiser, et al.Pediatric Surgery International|September 5, 2024
Improving care and survival of newborns with surgical conditions in Tanzania (TINY Tanzania): a focus on gastroschisisGodfrey Sama Philipo, Zaitun Mohamed Bokhary, Melanie Kapapa, et al.Nature Biotechnology|March 4, 2003
Enhancement of therapeutic protein in vivo activities through glycoengineeringSteve Elliott, Tony Lorenzini, Sheilah Asher, et al.Diabetes|March 22, 2022
Screening for Type 1 Diabetes in the General Population: A Status Report and PerspectiveEmily K Sims, Rachel E J Besser, Colin Dayan, et al.Pageof 16